Innovent Shares Jump on First Profit, Obesity Drug Momentum

Innovent Biologics Inc. shares saw their biggest gains in nearly five months, after the Chinese drugmaker posted its first annual profit thanks to surging demand for its weight-loss drug.

The Hong Kong-listed stock jumped as much as 7.75% on Friday, marking the steepest gain since Oct. 31.